回复王炳志、邓欢和曹兰致编辑的信，信的内容是关于：霍贾特·艾哈迈德扎德法尔、马库斯·埃斯勒。前列腺特异性膜抗原成像：前列腺癌诊断和治疗规划中的变革者。《欧洲泌尿外科杂志》。即将发表。https://doi.org/10.1016/j.eururo.2019.02.028：尽管其特异性略有局限，但前列腺特异性膜抗原成像仍是前列腺癌诊断和治疗规划中的变革者。 - Suppr

Suppr

超能文献

Reply to Bingzhi Wang, Huan Deng, and Lan Cao's Letter to the Editor re: Hojjat Ahmadzadehfar, Markus Essler. Prostate-specific Membrane Antigen Imaging: A Game Changer in Prostate Cancer Diagnosis and Therapy Planning. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2019.02.028: Despite its Slightly Limited Specificity, Prostate-specific Membrane Antigen Imaging is Still a Game Changer in Prostate Cancer Diagnosis and Therapy Planning.

作者信息

Ahmadzadehfar Hojjat, Essler Markus

机构信息

Department of Nuclear Medicine, University Hospital Bonn, Bonn, Germany.

出版信息

Eur Urol. 2019 Nov;76(5):e126-e127. doi: 10.1016/j.eururo.2019.05.028.

DOI:10.1016/j.eururo.2019.05.028

PMID:31151676

Abstract

摘要

相似文献

Reply to Bingzhi Wang, Huan Deng, and Lan Cao's Letter to the Editor re: Hojjat Ahmadzadehfar, Markus Essler. Prostate-specific Membrane Antigen Imaging: A Game Changer in Prostate Cancer Diagnosis and Therapy Planning. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2019.02.028: Despite its Slightly Limited Specificity, Prostate-specific Membrane Antigen Imaging is Still a Game Changer in Prostate Cancer Diagnosis and Therapy Planning.回复王炳志、邓欢和曹兰致编辑的信，信的内容是关于：霍贾特·艾哈迈德扎德法尔、马库斯·埃斯勒。前列腺特异性膜抗原成像：前列腺癌诊断和治疗规划中的变革者。《欧洲泌尿外科杂志》。即将发表。https://doi.org/10.1016/j.eururo.2019.02.028：尽管其特异性略有局限，但前列腺特异性膜抗原成像仍是前列腺癌诊断和治疗规划中的变革者。

Eur Urol. 2019 Nov;76(5):e126-e127. doi: 10.1016/j.eururo.2019.05.028.

Re: Hojjat Ahmadzadehfar, Markus Essler. Prostate-specific Membrane Antigen Imaging: A Game Changer in Prostate Cancer Diagnosis and Therapy Planning. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2019.02.028.

Eur Urol. 2019 Nov;76(5):e125. doi: 10.1016/j.eururo.2019.05.004. Epub 2019 May 17.

Reply to Chris R. Cardwell, Samy Suissa and Liam J. Murray's letter to the editor re: Helene Hartvedt Grytli, Morten Wang Fagerland, Sophie D. Fosså, Kristin Austlid Taskén. Association between use of β-blockers and prostate cancer-specific survival: a cohort study of 3561 prostate cancer patients with high-risk or metastatic disease. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2013.01.007.回复克里斯·R·卡德韦尔、萨米·苏伊萨和利亚姆·J·默里给编辑的信，内容涉及：海伦妮·哈特维特·格里特利、莫滕·王·法格兰德、索菲·D·福萨、克里斯汀·奥斯特利德·塔斯肯。β受体阻滞剂的使用与前列腺癌特异性生存率之间的关联：一项对3561例高危或转移性前列腺癌患者的队列研究。《欧洲泌尿外科杂志》。即将发表。http://dx.doi.org/10.1016/j.eururo.2013.01.007

Eur Urol. 2013 Jul;64(1):e11-2. doi: 10.1016/j.eururo.2013.03.045. Epub 2013 Apr 11.

Reply to Erfan Ayubi and Saeid Safiri's Letter to the Editor re: R. Jeffrey Karnes, Voleak Choeurng, Ashley E. Ross, et al. Validation of a Genomic Risk Classifier to Predict Prostate Cancer-specific Mortality in Men with Adverse Pathologic Features. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2017.03.036. Methodological Issues.对埃尔凡·阿尤比和赛义德·萨菲里致编辑的信的回复，主题为：R. 杰弗里·卡恩斯、沃莱克·乔恩、阿什利·E. 罗斯等人。用于预测具有不良病理特征男性前列腺癌特异性死亡率的基因组风险分类器的验证。《欧洲泌尿外科杂志》。即将发表。https://doi.org/10.1016/j.eururo.2017.03.036。方法学问题。

Eur Urol. 2017 Dec;72(6):e158-e159. doi: 10.1016/j.eururo.2017.05.030. Epub 2017 May 31.

Reply to Ola Bratt and Anna Öfverholm's Letter to the Editor re: Peter Ström, Tobias Nordström, Henrik Grönberg, Martin Eklund. The Stockholm-3 Model for Prostate Cancer Detection: Algorithm Update, Biomarker Contribution, and Reflex Test Potential. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2017.12.028.回复奥拉·布拉特和安娜·奥弗霍尔姆致编辑的信，信的内容涉及：彼得·斯特罗姆、托比亚斯·诺德斯特伦、亨里克·格伦伯格、马丁·埃克隆德。前列腺癌检测的斯德哥尔摩-3模型：算法更新、生物标志物贡献及反射试验潜力。《欧洲泌尿外科杂志》。即将发表。https://doi.org/10.1016/j.eururo.2017.12.028 。

Eur Urol. 2018 Jul;74(1):e10-e11. doi: 10.1016/j.eururo.2018.03.009. Epub 2018 Mar 26.

Reply to Andrew J. Vickers' Letter to the Editor re: Michael Baboudjian, Romain Diamand, Alessandro Uleri, et al. Does Overgrading on Targeted Biopsy of Magnetic Resonance Imaging-visible Lesions in Prostate Cancer Lead to Overtreatment? Eur Urol. In press. https://doi.org/10.1016/j.eururo.2024.02.003.回复安德鲁·J·维克斯致编辑的信，主题为：迈克尔·巴布吉安、罗曼·迪亚曼德、亚历山德罗·乌莱里等人。前列腺癌磁共振成像可见病灶靶向活检的过度分级会导致过度治疗吗？《欧洲泌尿外科杂志》。即将发表。https://doi.org/10.1016/j.eururo.2024.02.003 。

Eur Urol. 2024 Sep;86(3):e72. doi: 10.1016/j.eururo.2024.05.016. Epub 2024 May 24.

Reply to Jianhui Du, Yueguang Liu, and Weigang Yan's Letter to the Editor re: Gregory T. Chesnut, Emily A. Vertosick, Nicole Benfante, et al. Role of Changes in Magnetic Resonance Imaging or Clinical Stage in Evaluation of Disease Progression for Men with Prostate Cancer on Active Surveillance. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2019.12.009.

Eur Urol. 2020 Aug;78(2):e65-e66. doi: 10.1016/j.eururo.2020.04.050. Epub 2020 May 5.

Reply to Sungeun Kim, Jae Il Shin, and Jonathan Evan Shoag's Letter to the Editor re: Luca F. Valle, Eric J. Lehrer, Daniela Markovic, et al. A Systematic Review and Meta-analysis of Local Salvage Therapies After Radiotherapy for Prostate Cancer (MASTER). Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.11.010.回复孙根·金、宰一·申和乔纳森·埃文·肖格致编辑的信，内容涉及卢卡·F·瓦莱、埃里克·J·莱勒、丹妮拉·马尔科维奇等人的《前列腺癌放疗后局部挽救治疗的系统评价和荟萃分析（MASTER）》。《欧洲泌尿外科杂志》即将发表。https://doi.org/10.1016/j.eururo.2020.11.010

Eur Urol. 2021 Jul;80(1):e15-e16. doi: 10.1016/j.eururo.2021.04.010. Epub 2021 Apr 29.

Reply to Alessia Cimadamore, Liang Cheng, Antonio Lopez-Beltran, Marina Scarpelli, and Rodolfo Montironi's Letter to the Editor re: Scott Wilkinson, Huihui Ye, Fatima Karzai, et al. Nascent Prostate Cancer Heterogeneity Drives Evolution and Resistance to Intense Hormonal Therapy. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2021.03.009: Focus on Intraductal Carcinoma of the Prostate.回复阿莱西娅·奇马达莫尔、梁成、安东尼奥·洛佩斯 - 贝尔特兰、玛丽娜·斯卡佩利和罗多尔福·蒙蒂罗尼致编辑的信，信的主题为：斯科特·威尔金森、叶慧慧、法蒂玛·卡尔扎伊等人所著的《新生前列腺癌异质性驱动进展及对强化激素治疗的抵抗》。《欧洲泌尿外科杂志》即将发表。https://doi.org/10.1016/j.eururo.2021.03.009：聚焦前列腺导管内癌

Eur Urol. 2021 Sep;80(3):e83-e84. doi: 10.1016/j.eururo.2021.06.002. Epub 2021 Jun 18.

Reply to Hein V. Stroomberg, Klaus Brasso, and Andreas Røder's Letter to the Editor re: Michael Baboudjian, Romain Diamand, Alessandro Uleri, et al. Does Overgrading on Targeted Biopsy of Magnetic Resonance Imaging-visible Lesions in Prostate Cancer Lead to Overtreatment? Eur Urol. In press. https://doi.org/10.1016/j.eururo.2024.02.003.回复海因·V·斯特鲁姆伯格、克劳斯·布拉索和安德烈亚斯·勒德致编辑的信，内容关于：迈克尔·巴博吉安、罗曼·迪亚曼德、亚历山德罗·乌莱里等人。前列腺癌磁共振成像可见病灶靶向活检的过度分级会导致过度治疗吗？《欧洲泌尿外科杂志》。即将发表。https://doi.org/10.1016/j.eururo.2024.02.003 。

Eur Urol. 2024 Sep;86(3):e66. doi: 10.1016/j.eururo.2024.05.017. Epub 2024 May 24.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验